Healthpeak Properties, Inc. $DOC Shares Sold by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company reduced its position in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 5.8% during the 2nd quarter, Holdings Channel.com reports. The firm owned 662,019 shares of the real estate investment trust’s stock after selling 40,882 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Healthpeak Properties were worth $14,167,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of the company. Advocate Investing Services LLC purchased a new position in shares of Healthpeak Properties during the fourth quarter valued at approximately $26,000. Clearstead Trust LLC grew its stake in Healthpeak Properties by 66.7% in the 2nd quarter. Clearstead Trust LLC now owns 1,357 shares of the real estate investment trust’s stock worth $29,000 after acquiring an additional 543 shares during the period. Elyxium Wealth LLC purchased a new stake in Healthpeak Properties in the 4th quarter worth approximately $31,000. Clearstead Advisors LLC raised its holdings in Healthpeak Properties by 166.3% in the 4th quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust’s stock valued at $31,000 after acquiring an additional 1,216 shares during the last quarter. Finally, CYBER HORNET ETFs LLC acquired a new position in Healthpeak Properties in the 2nd quarter valued at $33,000. 93.57% of the stock is currently owned by hedge funds and other institutional investors.

Healthpeak Properties Stock Performance

Shares of DOC stock opened at $20.96 on Friday. The company has a debt-to-equity ratio of 1.06, a quick ratio of 3.02 and a current ratio of 3.02. The firm has a market capitalization of $14.45 billion, a price-to-earnings ratio of 59.89, a price-to-earnings-growth ratio of 2.32 and a beta of 1.01. Healthpeak Properties, Inc. has a one year low of $15.70 and a one year high of $22.95. The company has a 50 day moving average price of $21.54 and a 200 day moving average price of $19.18.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.05. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The company had revenue of $771.58 million for the quarter, compared to analyst estimates of $725.64 million. During the same quarter last year, the business earned $0.46 EPS. Healthpeak Properties’s revenue for the quarter was up 11.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. Sell-side analysts anticipate that Healthpeak Properties, Inc. will post 1.77 EPS for the current year.

Healthpeak Properties Dividend Announcement

The company also recently announced a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be given a $0.1017 dividend. This represents a c) annualized dividend and a dividend yield of 5.8%. The ex-dividend date of this dividend is Monday, September 14th. Healthpeak Properties’s dividend payout ratio (DPR) is 348.57%.

Analysts Set New Price Targets

A number of research analysts have weighed in on DOC shares. Royal Bank Of Canada increased their price target on Healthpeak Properties from $21.00 to $24.00 and gave the stock an “outperform” rating in a research note on Monday, August 10th. Citigroup lifted their price objective on Healthpeak Properties from $20.00 to $22.00 and gave the company a “neutral” rating in a research report on Tuesday, August 11th. UBS Group upped their target price on Healthpeak Properties from $19.00 to $21.50 and gave the company a “neutral” rating in a research note on Wednesday, July 8th. JPMorgan Chase & Co. increased their target price on Healthpeak Properties from $18.00 to $21.00 and gave the stock a “neutral” rating in a research report on Wednesday, June 24th. Finally, Wall Street Zen raised Healthpeak Properties from a “sell” rating to a “hold” rating in a research note on Sunday, May 10th. Four research analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $21.66.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.